TENAX THERAPEUTICS, INC. — Director's Dealing 2012

Sep 17, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXYGEN BIOTHERAPEUTICS, INC. (oxbt)
CIK: 0000034956
Period of Report: 2012-08-31

Reporting Person: Jebsen Michael B (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-31	common stock	A	14938	$1.84	Acquired	27623	Direct
2012-09-15	common stock	D	279	$0.88	Acquired	27344	Direct